Levetiracetam Micro Labs

Levetiracetam, the active ingredient in Levetiracetam Micro Labs, is an anticonvulsant presented as an oral dosage form for oral use. It is used to treat epilepsy, including partial and generalized seizures, in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Levetiracetam Micro Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that reduces seizure activity in the central nervous system.

- Epilepsy: helps control the frequency and severity of seizures. - Partial seizures: reduces focal seizure episodes. - Generalized seizures: diminishes tonic‑clonic and other generalized seizure types.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired. - Headache: mild to moderate pain. - Nausea: upset stomach. - Irritability: mood changes. - Somnolence: increased sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Mood disorders: depression, suicidal thoughts. - Stevens‑Johnson syndrome: severe skin blistering. - Blood dyscrasias: low white blood cells or platelets. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: toxic epidermal necrolysis.

When prescribing or dispensing Levetiracetam, consider the following safety measures.

- Renal impairment: adjust dose based on renal function. - Hepatic disease: monitor liver function tests. - Psychiatric history: watch for mood changes or depression. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy: evaluate risk‑benefit ratio; limited data available. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines): increased CNS depression. - Antidepressants (e.g., SSRIs): potential for mood alterations. - Immunosuppressants (e.g., cyclosporine): monitor for altered drug levels. - Oral contraceptives: limited evidence of reduced effectiveness; advise additional contraception.